Fig. 1From: Caveolin-1 expression predicts efficacy of weekly nab-paclitaxel plus gemcitabine for metastatic breast cancer in the phase II clinical trialFlowchart of phase II trial of nab-paclitaxel and gemcitabineBack to article page